Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China

Vaccine

Volumn 35, Issue 23, 2017, Pages 3129-3134

  Zhang, Yi ^a   Wu, Peng ^b   Feng, Luzhao ^a   Yang, Peng ^a   Pan, Yang ^a   Feng, Shuo ^b   Qin, Ying ^a   Zheng, Jiandong ^a   Puig Barberà, Joan ^c   Muscatello, David ^d   MacIntyre, Raina ^d   Cowling, Benjamin J ^b   Yu, Hongjie ^e   Wang, Quanyi ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Foundation for the Promotion of the Health and Biomedical Research in the Valencia Region   (Spain)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e FUDAN UNIVERSITY   (China)

Author keywords

Effectiveness; Hospitalization; Influenza; Test negative; Vaccine

Indexed keywords

INFLUENZA VACCINE; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHINA; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; SELF REPORT; SMOKING; VIRUS ISOLATION; AGED; CASE CONTROL STUDY; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA B VIRUS; ISOLATION AND PURIFICATION; MIDDLE AGED; SEASON; SENTINEL SURVEILLANCE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VACCINATION; VACCINE IMMUNOGENICITY;

ADULT; AGED; CASE-CONTROL STUDIES; CHINA; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOGENICITY, VACCINE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; SEASONS; SENTINEL SURVEILLANCE; VACCINATION;

EID: 85018714318     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.03.084     Document Type: Article

References (15)

1. Feng, L., Mounts, A.W., Feng, Y., Luo, Y., Yang, P., Feng, Z., et al. Seasonal influenza vaccine supply and target vaccinated population in China, 2004–2009. Vaccine 28 (2010), 6778–6782.
2. Lv, M., Fang, R., Wu, J., Pang, X., Deng, Y., Lei, T., et al. The free vaccination policy of influenza in Beijing, China: the vaccine coverage and its associated factors. Vaccine 34 (2016), 2135–2140.
3. Qin, Y., Zhang, Y., Wu, P., Feng, S., Zheng, J., Yang, P., et al. Influenza vaccine effectiveness in preventing hospitalization among Beijing residents in China, 2013–15. Vaccine 34 (2016), 2329–2333.
4. Tricco, A.C., Chit, A., Soobiah, C., Hallett, D., Meier, G., Chen, M.H., et al. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med, 11, 2013, 153.
5. Sullivan, S.G., Feng, S., Cowling, B.J., Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review. Expert Rev Vaccines 13 (2014), 1571–1591.
6. WHO Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza; 2011. < http://www.who.int/influenza/gisrs_laboratory/manual_diagnosis_surveillance_influenza/en/> [accessed December 18].
7. Beijing Municipal Statistics Bureau. Beijing statistical yearbook; 2015. < http://www.bjstats.gov.cn/nj/main/2015-tjnj/indexch.htm> [accessed December 18 2016].
8. Pebody, R., Warburton, F., Ellis, J., Andrews, N., Potts, A., Cottrell, S., et al. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results. Euro Surveill, 21, 2016.
9. Rebody, R., Sile, B., Warburton, F., Sinnathamby, M., Tsan, Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season. Euro Surveill, 22(4), 2017.
10. Chambers, C., Skowronski, D.M., Sabaiduc, S., Winter, A.L., Dickinson, J.A., De Serres, G., et al. Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016. Euro Surveill, 21, 2016, 30168.
11. Emborg, H.D., Krause, T.G., Nielsen, L., Thomsen, M.K., Christiansen, C.B., Skov, M.N., et al. Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16 – a rapid epidemiological and virological assessment. Euro Surveill, 21, 2016.
12. Kissling, E., Valenciano, M., Early influenza vaccine effectiveness results 2015–16: I-MOVE multicentre case-control study. Euro Surveill, 21, 2016.
13. Davlin, S.L., Blanton, L., Kniss, K., Mustaquim, D., Smith, S., Kramer, N., et al. Influenza activity – United States, 2015–16 season and composition of the 2016–17 influenza vaccine. MMWR Morb Mortal Wkly Rep 65 (2016), 567–575.
14. China National Influenza Center. Influenza report on week 19, 2016; 2016. < http://www.chinaivdc.cn/cnic/zyzx/lgzb/201606/t20160602_130511.htm> [accessed November 8 2016].
15. Zheng, Y., Yang, P., Wu, S., Ma, C., Seale, H., Macintyre, C.R., et al. A cross-sectional study of factors associated with uptake of vaccination against influenza among older residents in the postpandemic season in Beijing, China. BMJ Open, 3, 2013, e003662.